NVAX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Novavax, Inc. Shareholders of Class Action and Deadline: January 11, 2022

NEW YORK, NY / ACCESSWIRE / December 30, 2021 / Bronstein, Gewirtz & Grossman, LLC informs investors that a class action lawsuit has been filed against Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX) and certain of its officers, on behalf of shareholders who have purchased or otherwise acquired Novavax between March 2, 2021 and October 19, 2021 inclusive (the “Class Period”). These investors are encouraged to join this case by visiting the company’s website: www.bgandg.com/nvax.

This class action lawsuit seeks to recover damages against the defendants for alleged violations of federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the period of the action, the defendants made false and / or misleading statements and / or failed to disclose that: (1) Novavax overestimated its manufacturing capabilities and minimized the manufacturing problems which impact its approval schedule for NVX-CoV2373; (2) as a result, Novavax was unlikely to meet the EUA regulatory timelines for NVX-CoV2373; (3) as a result, the Company overestimated the regulatory and commercial outlook for NVX-CoV2373; and (4) accordingly, the Company’s public statements were materially false and misleading at all material times.

A class action has already been filed. If you would like to review a copy of the complaint, you can visit the firm’s website: www.bgandg.com/nvax or you can contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you have suffered harm at Novavax, you have until January 11, 2022 to request that the court appoint you as the principal plaintiff. Your ability to participate in any recovery does not require you to serve as the principal applicant.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our main expertise is the aggressive pursuit of contentious claims on behalf of our clients. In addition to representing institutions and other plaintiff investors in security class actions, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Lawyer advertising. Past results do not guarantee similar results.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]

THE SOURCE: Bronstein, Gewirtz and Grossman, LLC

See the source version on accesswire.com:
https://www.accesswire.com/677474/NVAX-Investor-Alert-Bronstein-Gewirtz-Grossman-LLC-Reminds-Novavax-Inc-Shareholders-of-Class-Action-and-Lead-Deadline-January-11- 2022


Source link

Comments are closed.